Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomised, Double Blind, Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer

NCT07095309 is registered in ClinicalTrials.gov with Metanoic Health Ltd. as lead sponsor.

NCT NCT07095309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07095309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomised, Double Blind, Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer
Lead sponsor
Metanoic Health Ltd.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 15, 2025
Completion date
July 31, 2033
Enrollment
120 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bowel cancer, stage ii/iii colon cancer